292 related articles for article (PubMed ID: 31954102)
1. Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A Cross-Sectional Analysis of the IPF-PRO Registry.
O'Brien EC; Hellkamp AS; Neely ML; Swaminathan A; Bender S; Snyder LD; Culver DA; Conoscenti CS; Todd JL; Palmer SM; Leonard TB;
Chest; 2020 May; 157(5):1188-1198. PubMed ID: 31954102
[TBL] [Abstract][Full Text] [Related]
2. The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry.
Kreuter M; Swigris J; Pittrow D; Geier S; Klotsche J; Prasse A; Wirtz H; Koschel D; Andreas S; Claussen M; Grohé C; Wilkens H; Hagmeyer L; Skowasch D; Meyer JF; Kirschner J; Gläser S; Kahn N; Welte T; Neurohr C; Schwaiblmair M; Held M; Bahmer T; Oqueka T; Frankenberger M; Behr J
Respir Res; 2019 Mar; 20(1):59. PubMed ID: 30876420
[TBL] [Abstract][Full Text] [Related]
3. Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry.
Kreuter M; Swigris J; Pittrow D; Geier S; Klotsche J; Prasse A; Wirtz H; Koschel D; Andreas S; Claussen M; Grohé C; Wilkens H; Hagmeyer L; Skowasch D; Meyer JF; Kirschner J; Gläser S; Herth FJF; Welte T; Neurohr C; Schwaiblmair M; Held M; Bahmer T; Frankenberger M; Behr J
Respir Res; 2017 Jul; 18(1):139. PubMed ID: 28709421
[TBL] [Abstract][Full Text] [Related]
4. Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry.
Case AH; Hellkamp AS; Neely ML; Bender S; Dilling DF; Gulati M; Hotchkin DL; Huie TJ; Lancaster L; Snyder LD; Conoscenti CS; Palmer SM
Ann Am Thorac Soc; 2020 Jun; 17(6):699-705. PubMed ID: 32040340
[No Abstract] [Full Text] [Related]
5. Validation of a derived version of the IPF-specific Saint George's Respiratory Questionnaire.
Prior TS; Hoyer N; Shaker SB; Davidsen JR; Hilberg O; Patel H; Bendstrup E
Respir Res; 2021 Oct; 22(1):259. PubMed ID: 34610840
[TBL] [Abstract][Full Text] [Related]
6. Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry.
Salisbury ML; Conoscenti CS; Culver DA; Yow E; Neely ML; Bender S; Hartmann N; Palmer SM; Leonard TB;
Ann Am Thorac Soc; 2020 Nov; 17(11):1413-1423. PubMed ID: 32574517
[No Abstract] [Full Text] [Related]
7. Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry.
Snyder L; Neely ML; Hellkamp AS; O'Brien E; de Andrade J; Conoscenti CS; Leonard T; Bender S; Gulati M; Culver DA; Kaner RJ; Palmer S; Kim HJ;
Respir Res; 2019 May; 20(1):105. PubMed ID: 31142314
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials.
Kreuter M; Wuyts WA; Wijsenbeek M; Bajwah S; Maher TM; Stowasser S; Male N; Stansen W; Schoof N; Orsatti L; Swigris J
Respir Res; 2020 Jan; 21(1):36. PubMed ID: 32000772
[TBL] [Abstract][Full Text] [Related]
9. Translation to Spanish and Validation of the Specific Saint George's Questionnaire for Idiopathic Pulmonary Fibrosis.
Capparelli I; Fernandez M; Saadia Otero M; Steimberg J; Brassesco M; Campobasso A; Palacios S; Caro F; Alberti ML; Rabinovich RA; Paulin F
Arch Bronconeumol (Engl Ed); 2018 Feb; 54(2):68-73. PubMed ID: 29102341
[TBL] [Abstract][Full Text] [Related]
10. The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis.
Swigris JJ; Han M; Vij R; Noth I; Eisenstein EL; Anstrom KJ; Brown KK; Fairclough D
Respir Med; 2012 Oct; 106(10):1447-55. PubMed ID: 22801586
[TBL] [Abstract][Full Text] [Related]
11. Development and validity testing of an IPF-specific version of the St George's Respiratory Questionnaire.
Yorke J; Jones PW; Swigris JJ
Thorax; 2010 Oct; 65(10):921-6. PubMed ID: 20861296
[TBL] [Abstract][Full Text] [Related]
12. Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry.
Wuyts WA; Dahlqvist C; Slabbynck H; Schlesser M; Gusbin N; Compere C; Maddens S; Rizzo S; Kirchgaessler KU; Bartley K; Bondue B
Pulm Ther; 2022 Jun; 8(2):181-194. PubMed ID: 35429319
[TBL] [Abstract][Full Text] [Related]
13. Depression Is Significantly Associated with the Health Status in Patients with Idiopathic Pulmonary Fibrosis.
Matsuda T; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Nishimura K; Nishiyama O; Sakamoto K; Hasegawa Y
Intern Med; 2017; 56(13):1637-1644. PubMed ID: 28674350
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry.
Todd JL; Neely ML; Overton R; Durham K; Gulati M; Huang H; Roman J; Newby LK; Flaherty KR; Vinisko R; Liu Y; Roy J; Schmid R; Strobel B; Hesslinger C; Leonard TB; Noth I; Belperio JA; Palmer SM;
Respir Res; 2019 Oct; 20(1):227. PubMed ID: 31640794
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry.
Glaspole IN; Chapman SA; Cooper WA; Ellis SJ; Goh NS; Hopkins PM; Macansh S; Mahar A; Moodley YP; Paul E; Reynolds PN; Walters EH; Zappala CJ; Corte TJ
Respirology; 2017 Jul; 22(5):950-956. PubMed ID: 28166611
[TBL] [Abstract][Full Text] [Related]
16. Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry.
Fan Y; Bender SD; Conoscenti CS; Davidson-Ray L; Cowper PA; Palmer SM; de Andrade JA;
Chest; 2020 Jun; 157(6):1522-1530. PubMed ID: 32004554
[TBL] [Abstract][Full Text] [Related]
17. The St. George's Respiratory Questionnaire as a prognostic factor in IPF.
Furukawa T; Taniguchi H; Ando M; Kondoh Y; Kataoka K; Nishiyama O; Johkoh T; Fukuoka J; Sakamoto K; Hasegawa Y
Respir Res; 2017 Jan; 18(1):18. PubMed ID: 28095852
[TBL] [Abstract][Full Text] [Related]
18. Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry.
Jo HE; Glaspole I; Moodley Y; Chapman S; Ellis S; Goh N; Hopkins P; Keir G; Mahar A; Cooper W; Reynolds P; Haydn Walters E; Zappala C; Grainge C; Allan H; Macansh S; Corte TJ
BMC Pulm Med; 2018 Jan; 18(1):19. PubMed ID: 29370786
[TBL] [Abstract][Full Text] [Related]
19. Lung function trajectories in patients with idiopathic pulmonary fibrosis.
Neely ML; Hellkamp AS; Bender S; Todd JL; Liesching T; Luckhardt TR; Oldham JM; Raj R; White ES; Palmer SM
Respir Res; 2023 Aug; 24(1):209. PubMed ID: 37612608
[TBL] [Abstract][Full Text] [Related]
20. Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis.
Nyilas S; Schreder T; Singer F; Poellinger A; Geiser TK; Latzin P; Funke M
Respirology; 2018 Aug; 23(8):764-770. PubMed ID: 29573509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
